Partnership for AI-accelerated
Compound Screening
We believe that true innovation thrives at the intersection of diverse expertise and shared visions. Across sectors, we work side-by-side with partners to translate natural potential into real-world impact, delivered with exceptional speed, efficiency, and accuracy.
Join the leaders who are already transforming their industries.
Join the leaders who are already transforming their industries.
Sectors
Pharmaceuticals
NYB’s proprietary AI, DTIGN, enhances hit identification and streamlines lead optimization by rapidly screening billions of natural compounds. This reduces R&D timelines and costs, ensuring your drug pipeline is filled with high-potential candidates that move quickly from discovery to clinical trials.
AI-accelerated compound screening
Dietary supplements
As consumer demand for natural, health-enhancing products grows, we identify potent bioactive compounds that help you create supplements offering measurable, trusted benefits
Evidence-based wellness
Functional food
We transform everyday ingredients into functional foods that support health and wellness. Our technology uncovers bioactive compounds that meet modern dietary trends, enabling you to create products that offer targeted health benefits.
Beyond basic nutrition
Beauty & personal care
Today’s audiences seek purity, sustainability, and proven results. We identify natural active ingredients that elevate product performance, resonating with conscientious consumers and setting new benchmarks in care.
Natural, clean, and science-backed
Trusted by Industry Leaders
Partner Stories
Discover how our partners have achieved remarkable milestones by leveraging NYB’s technology and expertise. From accelerated drug discoveries to breakthrough wellness products, see how our collaborations are making a meaningful difference.
Partnership
Nanyang Biologics Joins NVIDIA GTC 2025: Advancing AI in Drug Discovery
Nanyang Biologics is revolutionizing drug discovery with AI at NVIDIA GTC 2025! Discover how we’re using the latest technologies to accelerate life-saving innovations.
Partnership
Nanyang Biologics Joins Prestigious Johnson & Johnson Innovation JLABS to Accelerate AI-Driven Drug Discovery
Nanyang Biologics becomes a resident company of JLABS, joining a global network dedicated to accelerating life-enhancing health and wellness solutions.
Partnership
Nanyang Biologics Joins NVIDIA & Tribe’s Prestigious Ignition Program
Nanyang Biologics harnesses NVIDIA AI and accelerated computing to transform $7 billion drug discovery industry.
